GLUCAGEN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, Nigeria, Poland, Spain, Tunisia, UK.

Active ingredients

The drug GLUCAGEN contains one active pharmaceutical ingredient (API):

1
UNII 1H87NVF4DB - GLUCAGON HYDROCHLORIDE
 

Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract.

 
Read more about Glucagon

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 GLUCAGEN Powder and solvent for solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
H04AA01 Glucagon H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones
Discover more medicines within H04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 1449G, 3467L, 5105Q
BR Câmara de Regulação do Mercado de Medicamentos 526600201150415
ES Centro de información online de medicamentos de la AEMPS 59327
FI Lääkealan turvallisuus- ja kehittämiskeskus 443135, 443325
GB Medicines & Healthcare Products Regulatory Agency 33996
HK Department of Health Drug Office 41845
HR Agencija za lijekove i medicinske proizvode HR-H-628981009
IE Health Products Regulatory Authority 27027, 53492
IL מִשְׂרַד הַבְּרִיאוּת 642
LT Valstybinė vaistų kontrolės tarnyba 1004287
MT Medicines Authority MA104/00401, MA104/00402
NG Registered Drug Product Database A6-0445
Switch country to Nigeria in order to find specific presentations of GLUCAGEN
NL Z-Index G-Standaard 13675109, 13675117
NL Z-Index G-Standaard, PRK 35327, 35335
PL Rejestru Produktów Leczniczych 100205590
TN Direction de la Pharmacie et du Médicament 5993031, 5993033
US FDA, National Drug Code 0597-0053

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.